在阿尔茨海默氏病中,大脑网络枢纽退化
Suhui Jin1, Jinhui Wang1,2,3, Yong He4,5,6
1Institute for Brain Research and Rehabilitation, Guangzhou 510631, China.
Biophysics reports
|September 16, 2024
概括
阿尔茨海默病 (AD) 选择性地损害关键的大脑枢纽,影响网络功能. 了解这种大脑网络枢纽退化为AD机制,生物标志物和治疗提供了洞察力.
科学领域:
- 神经科学是一个神经科学.
- 医疗成像医学成像
- 计算生物学 计算生物学
背景情况:
- 阿尔茨海默病 (AD) 越来越多地被视为大脑网络功能障碍的疾病.
- 连接学和神经成像研究提供了新的方法来绘制AD脑网络的地图.
研究的目的:
- 对阿尔茨海默病中大脑网络枢纽退化的分子,成像和计算研究进行审查.
- 阐明AD网络功能障碍背后的生物学机制.
主要方法:
- 对分子,成像 (如MRI,PET) 和计算建模研究的审查.
- 对健康个体与AD患者的大脑枢纽分布和脆弱性的分析.
- 枢纽变性与分子 (粉样β),代谢和遗传因素的相关性.
主要成果:
- 高度连接的大脑枢纽位于健康个体的前额头,额头和部区域.
- 这些枢纽在AD中表现出选择性和严重的退化,由粉样蛋白沉积,缩,低代谢和连接性损失表明.
- 枢纽退化模式因成像方式而异:形态网络的中间时,白质网络的前额,功能网络的中间.
- 与AD相关的枢纽退化与代谢,分子和遗传因素相关.
结论:
- 大脑网络枢纽退化框架为了解AD病变发生提供了一个有前途的模型.
- 该框架强调了潜在的阿尔茨海默病诊断生物标志物和治疗点.
相关概念视频
Alzheimer's Disease: Overview
452
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
452
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
Dementia
107
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
107
Role of Neurotransmitters in Memory
482
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
482
Neurogenesis and Regeneration of Nervous Tissue
742
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
742


